Pacific Edge Limited PEB.NZ Stock
Pacific Edge Limited Price Chart
Pacific Edge Limited PEB.NZ Financial and Trading Overview
| Pacific Edge Limited stock price | 0.09 NZD |
| Previous Close | 0.1 NZD |
| Open | 0.1 NZD |
| Bid | 0.09 NZD x 1000000 |
| Ask | 0.1 NZD x 1621600 |
| Day's Range | 0.09 - 0.1 NZD |
| 52 Week Range | 0.05 - 0.84 NZD |
| Volume | 1.5M NZD |
| Avg. Volume | 1.14M NZD |
| Market Cap | 76.98M NZD |
| Beta (5Y Monthly) | 0.873946 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.03 NZD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.5 NZD |
PEB.NZ Valuation Measures
| Enterprise Value | 2.85M NZD |
| Trailing P/E | N/A |
| Forward P/E | -3.1666667 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.660185 |
| Price/Book (mrq) | 0.9313726 |
| Enterprise Value/Revenue | 0.135 |
| Enterprise Value/EBITDA | -0.09 |
Trading Information
Pacific Edge Limited Stock Price History
| Beta (5Y Monthly) | 0.873946 |
| 52-Week Change | -86.19% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.84 NZD |
| 52 Week Low | 0.05 NZD |
| 50-Day Moving Average | 0.39 NZD |
| 200-Day Moving Average | 0.45 NZD |
PEB.NZ Share Statistics
| Avg. Volume (3 month) | 1.14M NZD |
| Avg. Daily Volume (10-Days) | 4.81M NZD |
| Shares Outstanding | 810.36M |
| Float | 743.93M |
| Short Ratio | N/A |
| % Held by Insiders | 8.71% |
| % Held by Institutions | 30.11% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | -128.20% |
| Operating Margin (ttm) | -152.40% |
| Gross Margin | 55.55% |
| EBITDA Margin | -149.57% |
Management Effectiveness
| Return on Assets (ttm) | -19.43% |
| Return on Equity (ttm) | -28.21% |
Income Statement
| Revenue (ttm) | 21.03M NZD |
| Revenue Per Share (ttm) | 0.03 NZD |
| Quarterly Revenue Growth (yoy) | 65.00% |
| Gross Profit (ttm) | 11.68M NZD |
| EBITDA | -31461000 NZD |
| Net Income Avi to Common (ttm) | -26965000 NZD |
| Diluted EPS (ttm) | -0.03 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 77.79M NZD |
| Total Cash Per Share (mrq) | 0.1 NZD |
| Total Debt (mrq) | 1.22M NZD |
| Total Debt/Equity (mrq) | 1.48 NZD |
| Current Ratio (mrq) | 11.109 |
| Book Value Per Share (mrq) | 0.102 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -25575000 NZD |
| Levered Free Cash Flow (ttm) | -19389000 NZD |
Profile of Pacific Edge Limited
| Country | New Zealand |
| State | N/A |
| City | Dunedin |
| Address | Centre for Innovation |
| ZIP | 9016 |
| Phone | 64 3 479 5800 |
| Website | https://www.pacificedgedx.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 114 |
Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, Australia, and Singapore. The company operates in two segments, Commercial and Research. It offers Cxbladder, a genomic urine tests for the detection and management of bladder cancer. The company is also developing Cxbladder Resolve, a product that identifies those patients who are likely to have aggressive or more advanced bladder cancer; Cxbladder Triage, a product that identifies patients with haematuria who have a low probability of bladder cancer; Cxbladder Detect that enables the non-invasive detection of bladder and other urinary tract cancers; and Cxbladder Monitor, which allows urologists to monitor bladder cancer patients for recurrence of the disease. In addition, it is developing products for bladder, gastric, colorectal, endometrial cancers, and melanoma. The company was incorporated in 2001 and is headquartered in Dunedin, New Zealand.
Q&A For Pacific Edge Limited Stock
What is a current PEB.NZ stock price?
Pacific Edge Limited PEB.NZ stock price today per share is 0.09 NZD.
How to purchase Pacific Edge Limited stock?
You can buy PEB.NZ shares on the NZSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pacific Edge Limited?
The stock symbol or ticker of Pacific Edge Limited is PEB.NZ.
Which industry does the Pacific Edge Limited company belong to?
The Pacific Edge Limited industry is Diagnostics & Research.
How many shares does Pacific Edge Limited have in circulation?
The max supply of Pacific Edge Limited shares is 811.27M.
What is Pacific Edge Limited Price to Earnings Ratio (PE Ratio)?
Pacific Edge Limited PE Ratio is now.
What was Pacific Edge Limited earnings per share over the trailing 12 months (TTM)?
Pacific Edge Limited EPS is -0.03 NZD over the trailing 12 months.
Which sector does the Pacific Edge Limited company belong to?
The Pacific Edge Limited sector is Healthcare.
Pacific Edge Limited PEB.NZ included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| S&P/NZX ALL INDEX GROSS ( GROSS NZGI | 12889.62 NZD 7954.1 USD |
-0.5
|
— — | 12804.47 NZD 7901.56 USD | 12954.14 NZD 7993.92 USD | — - | — — |
| S&P/NZX 50 PORTFOLIO INDEX GROS NZC50 | 7438.77 NZD 4590.42 USD |
-0.65
|
— — | 7398.58 NZD 4565.62 USD | 7487.35 NZD 4620.39 USD | — - | — — |
| S&P/NZX MIDCAP INDEX ( CAPITAL NZMC | 5041.31 NZD 3110.96 USD |
-0.99
|
— — | 5032.63 NZD 3105.6 USD | 5091.82 NZD 3142.13 USD | — - | — — |
| S&P/NZX ALL INDEX ( CAPITAL IND NZCI | 1769.77 NZD 1092.11 USD |
-0.5
|
— — | 1758.03 NZD 1084.87 USD | 1778.58 NZD 1097.55 USD | — - | — — |
| S&P/NZX 50 INDEX GROSS ( GROSS NZ50 | 11872.34 NZD 7326.34 USD |
-0.49
|
— — | 11790.86 NZD 7276.06 USD | 11931.32 NZD 7362.74 USD | — - | — — |
- {{ link.label }} {{link}}